This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Tetra Bio-Pharma Management

Management criteria checks 3/4

Tetra Bio-Pharma's CEO is Guy Chamberland, appointed in Apr 2018, they has a tenure of 5.17 years. They directly owns 0.06% of the company’s shares, worth CA$7.77K. The average tenure of the management team and the board of directors is 2.8 years and 5.7 years respectively.`

Key information

Guy Chamberland

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure5.2yrs
CEO ownership0.06%
Management average tenure2.8yrs
Board average tenure5.7yrs

Recent management updates

Recent updates

Does Tetra Bio-Pharma (TSE:TBP) Have A Healthy Balance Sheet?

Sep 14
Does Tetra Bio-Pharma (TSE:TBP) Have A Healthy Balance Sheet?

CEO Compensation Analysis

How has Guy Chamberland's remuneration changed compared to Tetra Bio-Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Aug 31 2022n/an/a

-CA$39m

May 31 2022n/an/a

-CA$41m

Feb 28 2022n/an/a

-CA$45m

Nov 30 2021CA$437kCA$325k

-CA$52m

Aug 31 2021n/an/a

-CA$29m

May 31 2021n/an/a

-CA$28m

Feb 28 2021n/an/a

-CA$25m

Nov 30 2020CA$472kCA$298k

-CA$21m

Aug 31 2020n/an/a

-CA$17m

May 31 2020n/an/a

-CA$15m

Feb 29 2020n/an/a

-CA$14m

Nov 30 2019CA$295kCA$214k

-CA$13m

Aug 31 2019n/an/a

-CA$14m

May 31 2019n/an/a

-CA$10m

Feb 28 2019n/an/a

-CA$10m

Nov 30 2018CA$263kCA$191k

-CA$8m

Aug 31 2018n/an/a

-CA$5m

May 31 2018n/an/a

-CA$8m

Feb 28 2018n/an/a

-CA$7m

Nov 30 2017CA$153kCA$153k

-CA$6m

Aug 31 2017n/an/a

-CA$5m

May 31 2017n/an/a

-CA$4m

Feb 28 2017n/an/a

-CA$2m

Nov 30 2016CA$131kCA$60k

-CA$944k

Compensation vs Market: Insufficient data to establish whether Guy's total compensation is reasonable compared to companies of similar size in the Canadian market.

Compensation vs Earnings: Guy's compensation has been consistent with company performance over the past year.


CEO

Guy Chamberland (61 yo)

5.2yrs

Tenure

CA$436,642

Compensation

Dr. Guy Chamberland, M.Sc., Ph D., Master Herbalist, has been the Chief Executive Officer and Chief Regulatory Officer at Tetra Bio-Pharma Inc. since October 15, 2018 and serves as its Director since June...


Leadership Team

NamePositionTenureCompensationOwnership
Guy Chamberland
Co-Founder5.2yrsCA$436.64k0.060%
CA$ 7.8k
Steeve Néron
Chief Commercial Officer2.8yrsCA$313.61kno data
André Rancourt
Co-Founderno datano datano data
Leslie Auld
Chief Financial Officer1.1yrsno datano data
Jennifer McCaughey
Vice President of Investor Relationsno datano datano data
Dania Scott
Senior Vice President of Commercial Strategy2.8yrsno datano data
Aurelia Pauw
Senior VP of Clinical Programs & Medical Affairs2.4yrsno datano data
Richard Giguere
Chief Executive Officer of Tetra Natural Health Inc.4.7yrsno datano data
Randy Ringuette
Project Director & Member of Advisory Boardno datano datano data
Chris MacLean
Chief Operating Officer of Tetra Natural Health4.1yrsno datano data

2.8yrs

Average Tenure

Experienced Management: TBP's management team is considered experienced (2.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Guy Chamberland
Co-Founder4yrsCA$436.64k0.060%
CA$ 7.8k
Randy Ringuette
Project Director & Member of Advisory Board7.6yrsno datano data
Catherine Auld
Independent Director2.1yrsCA$56.76kno data
Steven Edgett
Member of Strategic Advisor2.9yrsno datano data
Brent Norton
Independent Chairman2.8yrsCA$151.76kno data
Adam Greenblatt
Member of Advisory Board7.6yrsno datano data
Erin Prosk
Member of Advisory Board7.6yrsno datano data
Charles Campbell
Member of Advisory Board7.6yrsno datano data
Louis-Philippe de Lorimier
Member of Clinical Advisory Board5.8yrsno datano data
Cheryl Cullen
Member of Clinical Advisory Board5.7yrsno datano data
Aubrey Webb
Member of Clinical Advisory Board5.7yrsno datano data
John Kim
Independent Director2.1yrsCA$56.76k0.096%
CA$ 12.4k

5.7yrs

Average Tenure

61yo

Average Age

Experienced Board: TBP's board of directors are considered experienced (5.7 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.